Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Conferences | Events

Sartorius employees to receive a bonus for their commitment and flexibility throughout 2021

publication date: Dec 20, 2021
author/source: Sartorius Group



Total amount of around 20 million euros

The life science company Sartorius will pay a total of around 20 million euros in special bonuses to employees in appreciation of their substantial commitment and special achievements in 2021. In Germany, this bonus will be 1,500 euros for each employee.

“The second exceptional year under pandemic conditions is coming to a close. The massively increased demand for our innovative solutions that are used in the development and production of vaccines and medicines has been challenging for our employees. They have gone the extra mile, or rather many extra miles, this year to ensure that we can reliably supply our customers with much needed products, and we would like to thank them very much for their efforts. As recognition for and appreciation of their work, Sartorius will again pay a special bonus to all employees,” said Sartorius Executive Board Chairman and CEO Joachim Kreuzburg.

The special bonus applies to more than 13,000 employees across the globe and will be paid out in December 2021. Last year, Sartorius had already paid a total of 10 million euros in coronavirus bonuses to more than 10,000 employees at that time.


About Sartorius

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.


Recent news from Sartorius


If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners